Ad
related to: how to treat ageusia disease symptoms in children
Search results
Results from the WOW.Com Content Network
Treatment for ageusia varies depending on its cause, whether it stems from certain illnesses, medications, traumatic injuries or other causes. If ageusia is triggered by a medication prescribed to a patient, discontinuing the medication under the guidance of a healthcare professional may alleviate the symptoms.
Dysgeusia is also often associated with ageusia, which is the complete lack of taste, and hypogeusia, which is a decrease in taste sensitivity. [1] An alteration in taste or smell may be a secondary process in various disease states, or it may be the primary symptom.
When treating oral cancer and related tumors, there is no clear treatment for hypogeusia. Precautions need to be studied and taken to prevent hypogeusia and related symptoms from forming. However, if the treatments have led to the formation of hypogeusia, than patient specific nutrition plans may be used to treat the loss of taste. [5]
The term childhood disease refers to disease that is contracted or becomes symptomatic before the age of 18 or 21 years old. Many of these diseases can also be contracted by adults. Some childhood diseases include:
Symptomatic treatment, supportive care, supportive therapy, or palliative treatment is any medical therapy of a disease that only affects its symptoms, not the underlying cause. It is usually aimed at reducing the signs and symptoms for the comfort and well-being of the patient, but it also may be useful in reducing organic consequences and ...
Jackie Galgey, 45, shares in a personal essay her experience with trigeminal neuralgia, also called the suicide disease, which caused her one-sided facial pain.
Chronic diseases in children may have a genetic (hereditary) cause, an environmental (acquired) cause or a combination of both. Early identification and treatment of the disease is key to successful health outcomes. Chronic diseases can affect multiple organ systems and can, therefore, manifest in different ways.
The RESTORE study (Reducing Exacerbations and Symptoms by Treatment with ORal Erdosteine in COPD) was a multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of erdosteine 300 mg/bid added to usual maintenance therapy vs. placebo over 12-months, a period long enough to avoid bias due to seasonal ...
Ad
related to: how to treat ageusia disease symptoms in children